908 Devices Inc. Common Stock (MASS) Stock
NASDAQ · MASS
11.51
Fundamentals
Market cap
$472.86M
Price / Earnings ratio
-13.7x
Price / Sales ratio
7.8x
Price / Book ratio
3.8x
Return on assets
-19.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Business Wire
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
NeutralMASSSeptember 1, 2026
Business WireNeutral
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
MASS

MarketBeat
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates
NeutralMASSAugust 30, 2026
MarketBeatNeutral
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates
MASS

MarketBeat
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
NeutralMASSAugust 18, 2026
MarketBeatNeutral
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
MASS

MarketBeat
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
NeutralMASSAugust 15, 2026
MarketBeatNeutral
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
MASS
Technicals
OscillatorsBuy5 Indicators
Moving AveragesStrong Buy12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral0
Buy3
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
67M45M22M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
228M151M75M0
Revenue to Profit
2025$56.2M
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$19.5M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Business Wire
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
NeutralMASSSeptember 1, 2026
Business WireNeutral
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
MASS

MarketBeat
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates
NeutralMASSAugust 30, 2026
MarketBeatNeutral
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates
MASS

MarketBeat
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
NeutralMASSAugust 18, 2026
MarketBeatNeutral
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
MASS

MarketBeat
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
NeutralMASSAugust 15, 2026
MarketBeatNeutral
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market
MASS

Business Wire
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
NeutralMASSAugust 12, 2026
Business WireNeutral
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
MASS

MarketBeat
908 Devices Q2 Earnings Call Highlights
NeutralMASSAugust 11, 2026
MarketBeatNeutral
908 Devices Q2 Earnings Call Highlights
MASS

Zacks Investment Research
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
NeutralMASSAugust 11, 2026
Zacks Investment ResearchNeutral
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
MASS

Business Wire
908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
NeutralMASSAugust 11, 2026
Business WireNeutral
908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
MASS

Zacks Investment Research
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
NeutralMASSAugust 4, 2026
Zacks Investment ResearchNeutral
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
MASS

Business Wire
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
NeutralMASSJuly 29, 2026
Business WireNeutral
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
MASS
About 908 Devices Inc. Common Stock
No description available.
SectorHealthcare
IndustryMedical Devices
Employees172
CEODr. Kevin J. Knopp Ph.D.
IPO DateDec 18, 2020
HeadquartersBurlington, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Kevin J. Knopp Ph.D. | Co-Founder, CEO, President & Director | 1973 |
| Dr. Christopher David Brown Ph.D. | Co-Founder, Board Advisor & Director | 1975 |
| Mr. Joseph H. Griffith IV | CFO & Treasurer | 1975 |
| Mr. Mark S. Levine J.D. | Chief Legal, Administrative Officer & Corporate Secretary | 1973 |
| Mr. John Kenneweg | Senior Vice President of Sales and Product Marketing | 1973 |
| Ms. Julie Cincotti | Global Head of Human Resources | — |
| Dr. Kevin McCallion Ph.D. | Senior Vice President of Products and Production | 1966 |
| Mr. Kola Otitoju | Chief Business & Strategy Officer | 1973 |
Fundamentals
Valuation
Market cap$472.86M
Price-to-sales ratio7.83
Price-to-book value3.76
Price-earnings ratio-13.70
Return on Equity-26.00%
Return on Sales-63.00%
Return on Assets-19.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.94
Income Statement
Average volume384,113
EBITDA$-31.82M
1 year high (52w)$11.53
1 year low (52w)$5.03
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsBuy5 Indicators
Moving AveragesStrong Buy12 Indicators
What the experts say
3 Wall Street Analyst Ratings
BUY
100% Buy
0% Hold
0% Sell
Target price
$12.83
Est return
12.13%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +1.3 | -5.9 | -32.6 | +7.8 | ||||||||
| 2022 | -39.8 | +2.0 | +14.1 | -13.9 | -24.0 | +52.9 | +4.9 | -10.8 | -10.1 | -3.4 | -31.8 | -27.4 |
| 2023 | +27.0 | -4.6 | -2.6 | -20.7 | +40.0 | -21.6 | -0.1 | +8.6 | -6.3 | -6.9 | +29.0 | +45.7 |
| 2024 | -28.6 | +1.9 | +2.7 | -17.4 | +10.9 | -16.9 | +19.3 | -22.2 | -6.7 | -7.6 | -20.8 | -23.3 |
| 2025 | +14.2 | -2.2 | +126.3 | +33.4 | +6.0 | +19.8 | +1.1 | -2.6 | +47.5 | -11.2 | -19.9 | -14.5 |
| 2026 | +24.0 | +11.5 | -7.4 | +10.0 | +23.5 | +0.8 | -9.8 | +26.7 | +7.4 |



